Sodium glucose transporter protein 2 inhibitors: focusing on the kidney to treat type 2 diabetes. | Ther Adv Endocrinol Metab;5(5): 124-36, 2014 Oct. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Sodium glucose transporter protein 2 inhibitors: focusing on the kidney to treat type 2 diabetes.

Peene, Bernard; Benhalima, Katrien.

Affiliation

Peene B; Department of Internal Medicine, UZ Gasthuisberg, KU Leuven, Leuven, Belgium.
Benhalima K; Endocrinology Department, UZ Gasthuisberg, Herestraat 49, 3300 Leuven, Belgium.

Ther Adv Endocrinol Metab ; 5(5): 124-36, 2014 Oct.

Article in En | MEDLINE | ID: mdl-25419452

Key words

canagliflozin; dapagliflozin; empagliflozin; sodium glucose transporter protein 2 inhibitors; type 2 diabetes

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ther Adv Endocrinol Metab Year: 2014 Document type: Article Affiliation country: Belgium

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ther Adv Endocrinol Metab Year: 2014 Document type: Article Affiliation country: Belgium